{"id": "1343592058490155013", "creation": 1609172284.0, "user_id": "621185967", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}}, "quoted": "1343504480789262336", "text": "\u201cSo far only @Pfizer has applied for emergency use approval of its #COVID19 #vaccine in the #Philippines, while [#China\u2019s] #Sinovac, [#Russia\u2019s] Gamaleya, @JNJNews's Janssen and @CloverBiophArma's late-stage trial applications have yet to be approved.\u201d #compliance https://t.co/J8tOdmEDhE", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE", "#PHILIPPINES", "#CHINA", "#SINOVAC", "#RUSSIA", "#COMPLIANCE"]}